Philadelphia Trust Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.2M | Sell |
180,065
-1,917
| -1% | -$425K | 2.76% | 10 |
|
|
2025
Q4 | $41.6M | Sell |
181,982
-3,741
| -2% | -$852K | 2.87% | 8 |
|
|
2025
Q3 | $43M | Sell |
185,723
-7,371
| -4% | -$1.5M | 3.03% | 6 |
|
|
2025
Q2 | $35.8M | Sell |
193,094
-2,615
| -1% | -$486K | 2.75% | 9 |
|
|
2025
Q1 | $41M | Sell |
195,709
-14,378
| -7% | -$2.8M | 3.51% | 5 |
|
|
2024
Q4 | $37.3M | Buy |
210,087
+2,322
| +1% | +$427K | 2.74% | 7 |
|
|
2024
Q3 | $41M | Buy |
207,765
+702
| +0.3% | +$131K | 2.98% | 6 |
|
|
2024
Q2 | $35.5M | Buy |
207,063
+1,379
| +0.7% | +$228K | 2.76% | 6 |
|
|
2024
Q1 | $37.5M | Buy |
205,684
+12,597
| +7% | +$2.17M | 3.01% | 6 |
|
|
2023
Q4 | $29.9M | Sell |
193,087
-2,290
| -1% | -$334K | 2.81% | 7 |
|
|
2023
Q3 | $29.1M | Sell |
195,377
-10,426
| -5% | -$1.53M | 2.99% | 6 |
|
|
2023
Q2 | $27.7M | Sell |
205,803
-4,520
| -2% | -$663K | 2.62% | 8 |
|
|
2023
Q1 | $33.5M | Sell |
210,323
-15,858
| -7% | -$2.42M | 3.41% | 5 |
|
|
2022
Q4 | $36.6M | Sell |
226,181
-21,304
| -9% | -$3.27M | 3.91% | 3 |
|
|
2022
Q3 | $33.2M | Buy |
247,485
+26,169
| +12% | +$3.76M | 3.76% | 3 |
|
|
2022
Q2 | $33.9M | Sell |
221,316
-20,000
| -8% | -$3.06M | 3.48% | 5 |
|
|
2022
Q1 | $39.1M | Sell |
241,316
-12,931
| -5% | -$1.88M | 3.09% | 7 |
|
|
2021
Q4 | $34.4M | Sell |
254,247
-13,896
| -5% | -$1.64M | 2.49% | 10 |
|
|
2021
Q3 | $28.9M | Sell |
268,143
-3,254
| -1% | -$372K | 2.13% | 18 |
|
|
2021
Q2 | $30.6M | Sell |
271,397
-3,825
| -1% | -$431K | 2.11% | 16 |
|
|
2021
Q1 | $29.8M | Sell |
275,222
-1,072
| -0.4% | -$115K | 2.29% | 13 |
|
|
2020
Q4 | $29.6M | Buy |
276,294
+2,015
| +0.7% | +$194K | 2.41% | 11 |
|
|
2020
Q3 | $24M | Buy |
274,279
+45,500
| +20% | +$4.28M | 2.32% | 15 |
|
|
2020
Q2 | $22.5M | Buy |
228,779
+205,516
| +883% | +$18.1M | 2.37% | 14 |
|
|
2020
Q1 | $1.77M | Sell |
23,263
-68,890
| -75% | -$5.87M | 0.22% | 65 |
|
|
2019
Q4 | $8.16M | Buy |
92,153
+18,065
| +24% | +$1.5M | 0.7% | 51 |
|
|
2019
Q3 | $5.61M | Buy |
74,088
+57,517
| +347% | +$3.94M | 0.52% | 61 |
|
|
2019
Q2 | $1.21M | Buy |
16,571
+865
| +6% | +$68K | 0.11% | 110 |
|
|
2019
Q1 | $1.27M | Sell |
15,706
-650
| -4% | -$53.2K | 0.11% | 99 |
|
|
2018
Q4 | $1.51M | Sell |
16,356
-1,021
| -6% | -$89.8K | 0.16% | 87 |
|
|
2018
Q3 | $1.64M | Sell |
17,377
-338
| -2% | -$32.1K | 0.13% | 96 |
|
|
2018
Q2 | $1.64M | Sell |
17,715
-175
| -1% | -$17.1K | 0.15% | 94 |
|
|
2018
Q1 | $1.69M | Sell |
17,890
-891
| -5% | -$97.9K | 0.14% | 97 |
|
|
2017
Q4 | $1.82M | Sell |
18,781
-360
| -2% | -$33.9K | 0.14% | 100 |
|
|
2017
Q3 | $1.7M | Buy |
19,141
+200
| +1% | +$15.2K | 0.14% | 100 |
|
|
2017
Q2 | $1.37M | Sell |
18,941
-83
| -0.4% | -$5.58K | 0.12% | 107 |
|
|
2017
Q1 | $1.24M | Buy |
19,024
+350
| +2% | +$22K | 0.1% | 113 |
|
|
2016
Q4 | $1.17M | Buy |
18,674
+575
| +3% | +$35.1K | 0.09% | 116 |
|
|
2016
Q3 | $1.14M | Buy |
18,099
+115
| +0.6% | +$7.45K | 0.1% | 117 |
|
|
2016
Q2 | $1.11M | Sell |
17,984
-360
| -2% | -$21.9K | 0.1% | 116 |
|
|
2016
Q1 | $1.05M | Sell |
18,344
-1,075
| -6% | -$59.9K | 0.09% | 105 |
|
|
2015
Q4 | $1.13M | Sell |
19,419
-2,290
| -11% | -$132K | 0.09% | 105 |
|
|
2015
Q3 | $1.18M | Buy |
21,709
+20,394
| +1,551% | +$1.33M | 0.11% | 95 |
|
|
2015
Q2 | $19.6K | Sell |
1,315
-18,364
| -93% | -$1.2M | 0.07% | 116 |
|
|
2015
Q1 | $1.15M | Sell |
19,679
-60
| -0.3% | -$3.63K | 0.09% | 110 |
|
|
2014
Q4 | $1.29M | Sell |
19,739
-145
| -0.7% | -$9.14K | 0.1% | 90 |
|
|
2014
Q3 | $1.15M | Sell |
19,884
-30,240
| -60% | -$1.68M | 0.07% | 96 |
|
|
2014
Q2 | $2.83M | Sell |
50,124
-299,588
| -86% | -$15.7M | 0.18% | 68 |
|
|
2014
Q1 | $18M | Sell |
349,712
-412
| -0.1% | -$20.8K | 1.13% | 42 |
|
|
2013
Q4 | $18.5M | Buy |
350,124
+4,496
| +1% | +$221K | 1.18% | 43 |
|
|
2013
Q3 | $15.5M | Buy |
345,628
+4,871
| +1% | +$216K | 1.07% | 43 |
|
|
2013
Q2 | $14.1M | Buy |
+340,757
| New | +$14.9M | 1.06% | 42 |
|
Other funds holding ABBV
VCM
VPM
Philadelphia Trust Company's ABBV Position: Q1 2026 in Review
Philadelphia Trust Company reduced its AbbVie (ABBV) stake by 1.1% in Q1 2026, selling an estimated $425K and leaving 180,065 shares worth $39.2M. The position accounts for 2.76% of the portfolio, ranked #10.
Philadelphia Trust Company first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $43M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Philadelphia Trust Company held 180,065 shares of AbbVie worth $39.2M as of Q1 2026.
- Philadelphia Trust Company sold 1,917 AbbVie shares in Q1 2026, an estimated $425K.
- AbbVie made up 2.76% of Philadelphia Trust Company's portfolio in Q1 2026, its #10 holding.
- Philadelphia Trust Company first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Philadelphia Trust Company's AbbVie position peaked at $43M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.